奖牌 发表于 2025-3-25 03:37:01

http://reply.papertrans.cn/16/1543/154252/154252_21.png

影响 发表于 2025-3-25 08:23:29

http://reply.papertrans.cn/16/1543/154252/154252_22.png

Fibrillation 发表于 2025-3-25 13:31:46

http://reply.papertrans.cn/16/1543/154252/154252_23.png

发现 发表于 2025-3-25 17:05:46

http://reply.papertrans.cn/16/1543/154252/154252_24.png

Nonconformist 发表于 2025-3-25 21:27:29

Development of Drugs for Alzheimer Therapy: A Decade of Progressre, some comparisons seem both useful and appropriate. In the seven years (1988–1994) since our first volume (Giacobini and Becker, 1988) we have identified approximately 100 compounds proposed for use in Alzheimer disease (AD) therapy. We have found reference to over 300 studies conducted in humans

octogenarian 发表于 2025-3-26 03:20:14

http://reply.papertrans.cn/16/1543/154252/154252_26.png

摄取 发表于 2025-3-26 05:16:45

http://reply.papertrans.cn/16/1543/154252/154252_27.png

忘恩负义的人 发表于 2025-3-26 09:51:13

http://reply.papertrans.cn/16/1543/154252/154252_28.png

尾巴 发表于 2025-3-26 14:41:27

Role of Abnormal Phosphorylation of Tau in Neurofibrillary Degeneration: Implications for Alzheimer hologically, Alzheimer disease (AD) is characterized by the presence of two brain lesions, paired helical filaments (PHF) in the neurons and ß-amyloid in the extracellular space. At present, the exact relationship between PHF and ß-amyloid in the pathogenesis of AD is not understood. However, there

大炮 发表于 2025-3-26 20:24:35

Olfactory Bulb Involvement in AD: An Early Changenaming of the odorant (Serby et al., 1985; Peabody and Tinklenberg, 1985; Warner et al., 1986; Knupfer and Speigel, 1986; Doty et al., 1987). In contrast, detecting the presence of an odorant (i.e. detection) or discriminating that two odorants are different (discrimination) appear to be relatively
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Alzheimer Disease; Therapeutic Strategi Ezio Giacobini (Chairman of Pharmacology),Robert E Conference proceedings 1994 Springer Science+Bus